Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Missouri for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Missouri only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Missouri (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kent Huston (NPI 1194739227)

Field	Value
Entity Type	Individual
Organization	Kent Huston
Address	4440 Broadway Blvd Ste 40
City	Kansas City
State	MO
ZIP	64111
Taxonomy	Rheumatology Physician
NPI Enumerated	July 27, 2006

Payer Source	Total Paid
Medicare	$1.5M
Medicaid	$0

Key Findings

This provider's commercial billing footprint is effectively single‑payer: total Medicare revenue is $1.5M while Medicaid billing is listed as none, indicating the practice relies on Medicare beneficiaries for all documented public program revenue. That concentration suggests analyses of payer risk or access barriers should treat this profile as Medicare‑centric rather than dual‑payer.

Revenue is heavily concentrated in office‑administered biologic drugs: J0717 ($505.6K, 33.6%), J0129 ($239.7K, 15.9%) and J1745 ($163.8K, 10.9%) together account for 60.4% of the provider's Medicare revenue. This mix is consistent with a rheumatology practice where drug administration (infused or clinic‑administered biologics) is the primary revenue driver rather than procedure‑based or diagnostic revenue.

Operationally, the CPT/HCPCS mix indicates an infusion/biologic administration model supported by ancillary infusion codes: 96413 ($37.8K), 96415 ($4.2K), and 96365 ($3.2K) appear on the claim list, showing capacity to deliver multi‑hour and initial intravenous infusions in addition to routine injections. Coupled with high claim counts for multiple injectable biologic codes, this pattern implies on‑site medication handling, infusion staffing, and related clinical workflows.

Competitive standing is mixed across individual drugs: the top revenue code J0717 ranks #93 of 848 (89th percentile) but is characterized in the data as typical, unremarkable volume for this code, while J0129 ranks #716 of 1221 (41th percentile) and J1745 ranks #236 of 1352 (83th percentile), both also labeled typical, unremarkable volume. These rank positions indicate the provider is neither an extreme national outlier for most biologics nor uniformly low‑volume across all drugs; market position varies by product.

Clinical visit volume is notable: 99214 contributes $80.1K from 921 claims and ranks #14027 of 479517 (97th percentile) with the dataset label notably above typical national volume. This elevated standing on mid‑level established patient visits suggests a steady, higher‑than‑average outpatient management load consistent with ongoing chronic disease follow‑up in rheumatology.

There are clear statistical outliers in ancillary services that signal on‑site procedural capacity: 96372 appears as an extreme outlier (849 claims, $9.3K), and phlebotomy/lab codes such as 36415 (1.2K claims, $4.6K; 97th percentile) and 85025 ($8.1K; 93th percentile) rank very high versus peers. The extreme outlier designation for 96372 and high percentiles for specimen and lab handling are consistent with frequent simple injections and in‑office testing beyond what many peers report.

Not all biologics are high relative to peers: J9312 (rituximab) yielded $74.9K but ranks #312 of 317 (2th percentile) and is described as typical, unremarkable volume for this code, while J3262 (tocilizumab) produced $118.2K and ranks #400 of 618 (35th percentile). This divergence suggests a drug‑specific prescribing pattern where certain biologics dominate the practice's mix while others are used less frequently compared with national cohorts.

The provider has long tenure on file, with NPI enumeration dated 2006-07-27 (~20 years ago), indicating an established practice history. That longevity, together with the high 99214 volume and sustained biologic administration revenue, is consistent with an entrenched outpatient rheumatology practice likely integrated into local referral patterns and chronic disease management pathways.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

46 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	126,400	$1	$505.6K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	7,050	$30	$239.7K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	6,300	$30	$163.8K
J3262	Injection, tocilizumab, 1 mg	29,560	$1	$118.2K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	2,350	$40	$84.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	920	$90	$80.1K
J1602	Injection, golimumab, 1 mg, for intravenous use	7,800	$10	$78K
J9312	Injection, rituximab, 10 mg	1,170	$60	$74.9K
J0897	Injection, denosumab, 1 mg	2,640	$20	$47.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	380	$100	$37.8K

Showing 1–10 of 46

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 46 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Missouri Distribution

Kent Huston — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Missouri

Full comparison — all codes billed, vs. state median

46 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	15	20	10,880	$30	$443.6K
J9312	9	10	3,350	$60	$315.8K
J1602	17	20	13,150	$10	$266.8K
J0717	2	10	61,500	$1	$259.7K
J3262	10	10	40,980	$1	$236.8K
J1569	10	10	4,350	$40	$171.2K
J1745	7	40	3,060	$30	$118.1K
J0897	91	210	2,400	$20	$82.4K
96413	28	160	140	$100	$19.1K
99214	160	8,960	100	$80	$13.9K

Showing 1–10 of 46

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kent Huston, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Christopher Koenig	KS	Rheumatology Physician	$2.3M	$0
Michael Smith	CO	Rheumatology Physician	$2M	$0
Kalista Engelman	MO	Rheumatology Physician	$1.7M	$0
Julian Magadan	MO	Rheumatology Physician	$1.7M	$0
Tina Shah	MO	Rheumatology Physician	$1.6M	$0
Shirley Wang	KS	Rheumatology Physician	$1.2M	$0
Ann Warner	MO	Rheumatology Physician	$911.8K	$0
Travis Sifers	MO	Allergy & Immunology (Internal Medicine) Physician	$614.2K	$0
Jeremy Sharp	KS	Rheumatology Physician	$433.9K	$0
Zachary Jacobs	MO	Allergy & Immunology Physician	$416.2K	$0

Nearby Providers

Other providers in the same ZIP code as Kent Huston, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Whole Person, Inc.	MO	In Home Supportive Care Agency	$0	$203.1M
Community Choice, Inc.	MO	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$19.6M
St Lukes Hospital Of Kansas City	MO	General Acute Care Hospital	$0	$18.7M
United Seating And Mobility LLC	MO	Durable Medical Equipment & Medical Supplies	$0	$8.8M
Midwest Home Health Care, Inc.	MO	Homemaker	$0	$4.3M
Michael Cassell	MO	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Hillary Bownik	MO	Gastroenterology Physician	$959.9K	$0
Medical Plaza Imaging Associates, LLC	MO	Diagnostic Radiology Physician	$802.8K	$129.4K
Manuel Camejo	MO	Ophthalmology Physician	$924.9K	$0
Mark Allen	MO	Gastroenterology Physician	$853.1K	$0

Kent Huston — Billing Profile & Reimbursement Data

Sign up for Kent Huston — Billing Profile & Reimbursement Data policy alerts

Kent Huston — Billing Profile & Reimbursement Data

Sign up for Kent Huston — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References